サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609555

ヘルスケアバイオコンバージェンスの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年

Healthcare Bioconvergence Market Size, Share & Trends Analysis Report By Application, By Region, and Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ヘルスケアバイオコンバージェンスの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年11月05日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルスケアバイオコンバージェンス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のヘルスケアバイオコンバージェンス市場規模は2030年までに2,152億米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 6.7%で拡大すると予測されており、その要因としては、高齢者の増加、損傷した細胞や組織、臓器を修復する利点に関する幹細胞技術の台頭、ロボット工学、機械学習、インテリジェントイメージング、人間工学（個人と環境の関係）、人工知能とライフサイエンスなどのハイテク技術や進歩の統合などが挙げられます。医療だけでなく、バイオコンバージェンスは、農業、エネルギー、食料、安全保障、気候など、さまざまなセグメントにも応用されています。

COVID-19の大流行は、投薬研究、保健技術、医療技術に大きな影響を与えました。AIやMLといったハイテク技術をバイオテクノロジー研究開発部門に取り入れることで、病原体の理解や、世界中に広がるウイルスを抑えるためのワクチンだけでなく医薬品の開発に役立った。先進的工学、生物学、物理学、計算科学が融合することで、医薬品開発のペースが大幅に向上しました。2021年の学術紙製Frontiers in Medicineによると、AIなどの先端技術は、COVID-19の効率的な診断、予後検査、流行予測、創薬に役立っています。

デジタルの進歩が受け入れられるようになったことで、クラウドベースのソリューションは製薬産業で飛躍的なスピードで進化していくと考えられます。再生医療は、生体内修復のための要素を提供するために、生命科学、先端工学、ロボット工学、コンピュータサイエンス、オートメーションと専門知識を融合させることによって進化しています。

ヘルスケアバイオコンバージェンス市場レポートのハイライト

  • 用途別では、創薬が2024年に20.46%の収益シェアで市場を独占し、2025～2030年のCAGRは8.2%と最も早いと予想されます。この背景には、神経系疾患や循環器系疾患など幅広い疾患の頻度の増加、医療費の増大、一般的な医薬品の特許切れなどがあります。
  • 再生医療セグメントは、パーキンソン病、アルツハイマー病、脳損傷組織修復などの慢性疾患の治療や、標的指向型、部位特異的な正確なドラッグデリバリーによる慢性疾患の治療に卓越した可能性があるため、2025～2030年にかけて最も速いCAGR 8.7%を記録する可能性が高いです。
  • 2024年には、欧州が30.13％の収益シェアで市場を独占しています。これは、革新的な医療科学的治療を特定・創出するための強固な基盤となる、主要な研究機関、病院、医療センターの存在によるものです。

目次

第1章 調査範囲と目的

第2章 調査手法

  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • 商品フロー分析（モデル1）
    • 数量価格分析（モデル2）
  • 二次情報一覧

第3章 エグゼクティブサマリー

第4章 市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
  • ヘルスケアバイオコンバージェンス市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 医療コンバージェンス：ビジネス環境分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
  • 浸透と成長の展望マッピング
  • COVID-19がヘルスケアバイオコンバージェンス市場に与える影響

第5章 ヘルスケアバイオコンバージェンス市場：用途分析

  • ヘルスケアバイオコンバージェンスの用途市場シェア分析、2024年と2030年
  • ヘルスケアバイオコンバージェンスの用途市場：セグメントダッシュボード
  • 用途市場規模と予測と動向分析、2018～2030年

第6章 ヘルスケアバイオコンバージェンス市場：地域分析

  • ヘルスケアバイオコンバージェンスの地域市場シェア分析、2024年と2030年
  • 地域市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合分析

  • 主要市場参入企業による最近の動向と影響分析
  • 企業プロファイル
    • Biomx.
    • Singota Solution
    • Anima BIoTech Inc.
    • Ginkgo Bioworks
    • Setpoint Medical Corporation
    • Galvani Bioelectronics
    • Bico-The Bio Convergence Company
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 North America healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 3 North America healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 Canada healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 6 Mexico healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 7 Europe healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 8 Europe healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 UK healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 10 Germany healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 11 France healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 12 Italy healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Spain healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14 Russia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 15 Denmark healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 16 Sweden healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 20 Japan healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 21 China healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 22 India healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23 Australia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 24 South Korea healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 25 Singapore healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 Thailand healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 30 Argentina healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 31 Colombia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 32 MEA healthcare bioconvergence market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 37 Israel healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38 Kuwait healthcare bioconvergence market estimates and forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Healthcare bioconvergence market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Healthcare bioconvergence market outlook, 2024 (USD Million)
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Healthcare bioconvergence application market share analysis, 2024 & 2030 (USD Million)
  • Fig. 15 Healthcare bioconvergence application market: Segment dashboard
  • Fig. 16 Drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 17 Nanorobotics for drug delivery market, 2018 - 2030 (USD Million)x1
  • Fig. 18 Regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 19 Diagnostic and biological sensors market, 2018 - 2030 (USD Million)
  • Fig. 20 Bioelectronics market, 2018 - 2030 (USD Million)
  • Fig. 21 Engineered living materials market, 2018 - 2030 (USD Million)
  • Fig. 22 Optogenetics market, 2018 - 2030 (USD Million)
  • Fig. 23 Precision medicine health market, 2018 - 2030 (USD Million)
  • Fig. 24 Healthcare bioconvergence regional market share analysis, 2021 & 2030 (USD Million)
  • Fig. 25 Regional market place: Key takeaways
  • Fig. 26 North America healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 30 Europe healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 31 UK healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 33 France healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 34 Italy healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 35 Spain healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 36 Russia healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 39 Norway healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 41 Japan healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 42 China healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 43 India healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 44 Australia healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 46 Singapore healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 51 Colombia healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 52 MEA healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 55 UAE healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 56 Israel healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 57 Israel healthcare bioconvergence market, 2018 - 2030 (USD Million)
  • Fig. 58 Strategy framework
目次
Product Code: GVR-4-68040-012-5

Healthcare Bioconvergence Market Growth & Trends:

The global healthcare bioconvergence market size is expected to reach USD 215.2 billion by 2030, based on a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.7% from 2025 to 2030, owing to factors including the growing geriatric population, rising stem cell technology regarding the advantages of fixing damaged cells, tissues as well as organs, and the integration of high-tech technologies and advancements such as robotics, machine learning, intelligent imaging, ergonomics (relationship between individuals and their environment), and artificial intelligence with life science. Besides healthcare, bioconvergence is finding applications in a variety of other areas as well, including agriculture, energy, food, security, climate, and others.

The COVID-19 pandemic has significantly impacted medication research, health technology, and medical technology. The incorporation of high-tech technologies such as AI and ML into the biotech research and development sector aided in understanding the pathogen and developing drugs as well as vaccines to control the spread of the virus across the globe. The amalgamation of advanced engineering, biology, physics, and computational sciences, has significantly increased the pace of drug development. According to the 2021 academic paper Frontiers in Medicine, advanced technologies such as AI have helped in efficient diagnosis, prognosis examination, epidemic prediction, and drug discovery for COVID-19.

With the rise in terms of acceptance of digital advancements, cloud-based solutions are likely to evolve in the pharmaceutical industry at an exponential pace. Regenerative medicine is evolving by merging expertise knowledge with life science, advanced engineering, robotics, computer science, and automation to provide elements for in-vivo repair.

Healthcare Bioconvergence Market Report Highlights:

  • Based on application, drug discovery dominates dominated the market in terms of the revenue share of 20.46% in 2024 and is expected to witness the fastest CAGR of 8.2% from 2025 to 2030. This is attributable to the growing frequency of a broad range of ailments (such as nervous system-related disorders, and circulatory disorders), mounting medical costs, as well as the approaching patent termination of popular drugs
  • The regenerative medicine segment is likely to witness the fastest CAGR of 8.7% from 2025 to 2030 owing to its exceptional potential to treat chronic diseases such as Parkinson's disease, Alzheimer's disease, brain injury tissue repair, and to treat chronic diseases by target-oriented, and site-specific delivery of precise drugs
  • In 2024, Europe dominated the market with a revenue share of 30.13%, owing to the presence of leading research institutes, hospitals, and medical centers which serve a solid basis for identifying and creating innovative medical and scientific treatments

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation & Scope
  • 1.2 Regional Scope
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3

Chapter 2 Methodology

  • 2.1 Research Methodology
  • 2.2 Information Procurement
    • 2.2.1 Purchased Database
    • 2.2.2 GVR's Internal Database
    • 2.2.3 Secondary Sources
    • 2.2.4 Primary Research
  • 2.3 Information Or Data Analysis
    • 2.3.1 Data Analysis Models
  • 2.4 Market Formulation & Validation
  • 2.5 Model Details
    • 2.5.1 Commodity Flow Analysis (Model 1)
    • 2.5.2 Volume Price Analysis (Model 2)
  • 2.6 List Of Secondary Sources

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 Application
    • 3.2.4 Region
  • 3.3 Competitive Insights
  • 3.4 Healthcare Bioconvergence Market Outlook, 2024

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Healthcare Bioconvergence Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Healthcare Bioconvergence: Business Environment Analysis Tools
    • 4.3.1 Porter's Five Forces Analysis
      • 4.3.1.1 Competitive Rivalry
      • 4.3.1.2 Threat Of Substitutes
      • 4.3.1.3 Threat Of Entrants
      • 4.3.1.4 Bargaining Power Of Buyers
      • 4.3.1.5 Bargaining Power Of Suppliers
    • 4.3.2 Pestel Analysis
      • 4.3.2.1 Political & Legal
      • 4.3.2.2 Economic & Social
      • 4.3.2.3 Technological
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Impact Of COVID-19 On Healthcare Bioconvergence Market

Chapter 5 Healthcare Bioconvergence Market: Application Analysis

  • 5.1 Healthcare Bioconvergence Application Market Share Analysis, 2024 & 2030
  • 5.2 Healthcare Bioconvergence Application Market: Segment Dashboard
  • 5.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Application Segment
    • 5.3.1 Drug Discovery
      • 5.3.1.1 Drug Discovery Market, 2018 - 2030 (USD Million)
    • 5.3.2 Nanorobotics For Drug Delivery
      • 5.3.2.1 Nanorobotics For Drug Delivery Market, 2018 - 2030 (USD Million)
    • 5.3.3 Regenerative Medicine
      • 5.3.3.1 Regenerative Medicine Market, 2018 - 2030 (USD Million)
    • 5.3.4 Diagnostic And Biological Sensors
      • 5.3.4.1 Diagnostic And Biological Sensors Market, 2018 - 2030 (USD Million)
    • 5.3.5 Bioelectronics
      • 5.3.5.1 Bioelectronics Market, 2018 - 2030 (USD Million)
    • 5.3.6 Engineered Living Materials
      • 5.3.6.1 Engineered Living Materials Market, 2018 - 2030 (USD Million)
    • 5.3.7 Optogenetics
      • 5.3.7.1 Optogenetics Market, 2018 - 2030 (USD Million)
    • 5.3.8 Precision Medicine
      • 5.3.8.1 Precision Medicine Market, 2018 - 2030 (USD Million)

Chapter 6 Healthcare Bioconvergence Market: Regional Analysis

  • 6.1 Healthcare Bioconvergence Regional Market Share Analysis, 2024 & 2030
  • 6.2 Regional Market Snapshot
  • 6.3 North America
    • 6.3.1 North America Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.3.4 Mexico
      • 6.3.4.1 Mexico Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.4.2 UK
      • 6.4.2.1 UK Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.4.5 Italy
      • 6.4.5.1 Italy Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.4.6 Spain
      • 6.4.6.1 Spain Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.4.7 Russia
      • 6.4.7.1 Russia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.3.8 Denmark
      • 6.3.8.1 Denmark Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.3.9 Sweden
      • 6.3.9.1 Sweden Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.3.10 Norway
      • 6.3.10.1 Norway Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.2 Japan
      • 6.5.2.1 Japan Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.3 China
      • 6.5.3.1 China Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.4 India
      • 6.5.4.1 India Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.6 South Korea
      • 6.5.6.1 South Korea Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.7 Singapore
      • 6.5.7.1 Singapore Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.5.8 Thailand
      • 6.5.8.1 Thailand Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.6.2 Brazil
      • 6.6.2.1 Brazil Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.6.3 Mexico
      • 6.6.3.1 Mexico Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.6.4 Argentina
      • 6.6.4.1 Argentina Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.6.5 Colombia
      • 6.6.5.1 Colombia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
  • 6.7 Middle East And Africa (MEA)
    • 6.7.1 MEA Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.7.3.1 Saudi Arabia Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.7.5 Israel
      • 6.7.5.1 Israel Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)
    • 6.7.6 Kuwait
      • 6.7.6.1 Kuwait Healthcare Bioconvergence Market, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company Profiles
    • 7.2.1 Biomx.
      • 7.2.1.1 Company Overview
      • 7.2.1.2 Financial Performance
      • 7.2.1.2 Product Benchmarking
      • 7.2.1.3 Strategic Initiatives
    • 7.2.2 Singota Solution
      • 7.2.2.1 Company Overview
      • 7.2.2.2 Product Benchmarking
    • 7.2.3 Anima Biotech Inc.
      • 7.2.3.1 Company Overview
      • 7.2.3.3 Product Benchmarking
    • 7.2.4 Ginkgo Bioworks
      • 7.2.4.1 Company Overview
      • 7.2.4.2 Product Benchmarking
      • 7.2.4.3 Strategic Initiatives
    • 7.2.5 Setpoint Medical Corporation
      • 7.2.5.1 Company Overview
      • 7.2.5.2 Product Benchmarking
      • 7.2.5.3 Strategic Initiatives
    • 7.2.6 Galvani Bioelectronics
      • 7.2.6.1 Company Overview
      • 7.2.6.2 Product Benchmarking
    • 7.2.7 Bico - The Bio Convergence Company
      • 7.2.7.1 Company Overview
      • 7.2.7.2 Financial Performance
      • 7.2.7.3 Product Benchmarking
      • 7.2.7.4 Strategic Initiatives